Work

Risk-adjusted survival for melanoma brain metastases in the era of checkpoint blockade immunotherapies: Results from a national cohort.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.2011

Authors: Bryan Iorgulescu, Maya Harary, Cheryl Zogg, Keith L. Ligon, David A. Reardon, F. Stephen Hodi, Ayal Aaron Aizer, Timothy Smith

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Brigham Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889560660

Cites:

Cited by: 1

Related to: 10